Tag Archives: Stupendous

Market Analysis

Stupendous Growth Observed in Global Genetic Testing Market

According to our latest report entitled, “Global Genetic Testing Market Analysis”, global genetic testing market witnessed a rapid growth rate in the recent years on the back of factors, such as increasing awareness level, rising prevalence of genetic disorders, and private sector participation. Recent industry developments and discovery of new genes are attracting a large number of global market players in the genetic tests segment. The market too has reached to the mark of around US$ 1.5 Billion in 2010 and is likely to grow at a CAGR of around 25% during 2012-2015.

We have found that DTC genetic test segment is fetching lots of attention from regulatory authorities and other concerned players. The concern over the selling of genetic tests directly to consumers and adoption of other advertising means has caused FDA intervention in the matter. Other countries are also pondering over the probable solution and it is expected that new regulations for DTC genetic tests may come in near future.

The report analyzes factors critical to the fast pace growth of the global genetic testing market. The report sheds light on the recent industry developments in which key product launches and strategic acquisitions among players have been covered in a prudent manner. Additionally, the report properly investigates the regulatory landscape with regards to genetic testing in key regions of the world.

The report, “Global Genetic Testing Market Analysis”, is an outcome of an extensive research and presents an in-depth analysis of the global genetic testing market. It provides future forecast on the market based on the correlation of past drivers, challenges, and opportunities for expansion. Key features of genetic testing market in key countries of the globe have been presented effectively. Last though not the least, a useful description of key market players and their products is also included in the report. Overall, the report is likely to provide clients a better understanding of genetic testing market.

Market Analysis

US Generics Market Poised For Stupendous Growth

According to our research report, “Booming US Generic Drug Market”, the generic drug sector in the US is one of the fastest growing sectors, both in terms of drug sales as well as prescriptions. The growth is primarily driven by prominent factors, such as patent expiration of key blockbuster drugs, price differences, aging population, and government support. The generic drugs industry in the US was valued at US$ 81.5 Billion in 2010, and is expected to grow further at a CAGR of around 10% during 2010-2013.

Our research revealed human insulin segment to offer a significant growth potential for generics players as diabetes prevalence is rapidly increasing and there are key drugs going off-patent in the near future. Humalog and Novolog are the key drugs whose patents are likely to get expired in 2014 and 2017, respectively. Moreover, the cost of insulin in the US is one the highest in the world and no generic version of drugs is available at present.

The report, “Booming US Generic Drug Market”, illustrates the market potential for human insulin segment and covers detailed analysis on other related segments, such as lipid regulator, antipsychotics, angiotensin II receptor, anti-depressants, ppi etc. It also investigates the recent market trends and analyzes their impact on the market performance. These trends have been identified after an in-depth analysis of market developments and industry focus.

In short, the report is an outcome of an extensive research and prudent analysis of the US generics market that effectively evaluates past, present, and future market performance. The forecasts in the report make use of proper base and methods so that future outlook may be more realistic. Overall, the report is likely to provide clients with a significant insight into the US generics market.